Document ID: FMCSA-2012-0094-0021
Agency: fmcsa
Document Type: Notice
Title: Qualification of Drivers; Exemption Applications: Epilepsy and Seizure Disorders; Denials
Posted Date: 2014-10-01T04:00Z

[Federal Register Volume 79, Number 190 (Wednesday, October 1, 2014)]
[Notices]
[Pages 59346-59348]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-23437]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Motor Carrier Safety Administration

[Docket No. FMCSA-2011-0089; FMCSA-2011-0389; FMCSA-2012-0050; FMCSA-
2012-0094; FMCSA-2013-0106; FMCSA-2013-0108; FMCSA-2013-0109]

Denial of Exemption Applications; Epilepsy and Seizure Disorders

AGENCY: Federal Motor Carrier Safety Administration (FMCSA), DOT.

ACTION: Notice of denial of applications for seizure exemptions.

-----------------------------------------------------------------------

SUMMARY: FMCSA announces the denial of 24 individuals' applications for 
exemptions from the rule prohibiting persons with a clinical diagnosis 
of epilepsy or any other condition that is likely to cause a loss of 
consciousness or any loss of ability to operate a commercial motor 
vehicle (CMV) from operating CMVs in interstate commerce. The reason 
for each of the denials is listed after the individual's name.

FOR FURTHER INFORMATION CONTACT: Elaine M. Papp, R.N., Chief of the 
Medical Programs Division, (202) 366-4001, fmcsamedical@dot.gov, FMCSA, 
Room W64-224, Department of Transportation, 1200 New Jersey Avenue SE., 
Washington, DC 20590-0001. Office hours are from 8:30 a.m. to 5 p.m., 
Monday through Friday, except Federal holidays.

SUPPLEMENTARY INFORMATION:

Background

    Under 49 U.S.C. 31315 and 31136(e), FMCSA may grant an exemption 
for a 2-year period if it finds ``such exemption would likely achieve a 
level of safety that is equivalent to, or greater than, the level that 
would be achieved absent such exemption.'' The statutes allow the 
Agency to renew exemptions at the end

[[Page 59347]]

of the 2-year period. The 24 individuals listed in this notice have 
requested an exemption from the epilepsy and seizure disorder standard 
in 49 CFR 391.41(b)(8), which applies to drivers who operate CMVs as 
defined in 49 CFR 390.5, in interstate commerce. Section 391.41(b)(8) 
states that a person is qualified physically to drive a CMV if that 
person has no established medical history or clinical diagnosis of 
epilepsy or any other condition which is likely to cause the loss of 
consciousness or any loss of ability to control a CMV.
    In order to make an evidence-based decision, FMCSA conducted a 
comprehensive review of scientific literature and convened a panel of 
medical experts in the field of neurology to evaluate key questions 
regarding seizure and anti-seizure medication related to the safe 
operation of a CMV. In reaching the determination to grant or deny 
exemption requests for individuals who have experienced a seizure, the 
Agency considered both current medical literature and information and 
the 2007 recommendations of the Agency's Medical Expert Panel (MEP). 
Previously, the Agency gathered evidence for decision making concerning 
potential changes to the regulation by conducting a comprehensive 
review of scientific literature that was compiled into a report 
entitled, ``Evidence Report on Seizure Disorders and Commercial Vehicle 
Driving'' (Evidence Report) [CD-ROM HD TL230.3 .E95 2007]. The Agency 
then convened a MEP in the field of neurology on May 14-15, 2007, to 
review 49 CFR 391.41(b)(8) and the advisory criteria regarding 
individuals who have experienced a seizure and the 2007 Evidence 
Report. The Evidence Report and the MEP recommendations are published 
on-line at http://www.fmcsa.dot.gov/rules-regulations/topics/mep/mep-reports.htm under Seizure Disorders and are in the docket for this 
notice.

MEP Criteria for Evaluation

    On October 15, 2007, the MEP issued the following recommended 
criteria for evaluating whether an individual with epilepsy or a 
seizure disorder should be allowed to operate a CMV.\1\ The MEP 
recommendations are included in an appendix at the end of this notice 
and in each of the previously published dockets.
---------------------------------------------------------------------------

    \1\ Engel, J., Fisher, R.S., Krauss, G.L., Krumholz, A., and 
Quigg, M.S., ``Expert Panel Recommendations: Seizure Disorders and 
Commercial Motor Vehicle Driver Safety,'' FMCSA, October 15, 2007.
---------------------------------------------------------------------------

    Epilepsy diagnosis. If there is an epilepsy diagnosis, the 
applicant should be seizure-free for 8 years, on or off medication. If 
the individual is taking anti-seizure medication(s), the plan for 
medication should be stable for 2 years. Stable means no changes in 
medication, dosage, or frequency of medication administration. 
Recertification for drivers with an epilepsy diagnosis should be 
performed every year.
    Single unprovoked seizure. If there is a single unprovoked seizure 
(i.e., there is no known trigger for the seizure), the individual 
should be seizure-free for 4 years, on or off medication. If the 
individual is taking anti-seizure medication(s), the plan for 
medication should be stable for 2 years. Stable means no changes in 
medication, dosage, or frequency of medication administration. 
Recertification for drivers with a single unprovoked seizure should be 
performed every 2 years.
    Single provoked seizure. If there is a single provoked seizure 
(i.e., there is a known reason for the seizure), the Agency should 
consider specific criteria that fall into the following two categories: 
Low-risk factors for recurrence and moderate-to-high risk factors for 
recurrence.
     Examples of low-risk factors for recurrence include 
seizures that were caused by a medication; by non-penetrating head 
injury with loss of consciousness less than or equal to 30 minutes; by 
a brief loss of consciousness not likely to recur while driving; by 
metabolic derangement not likely to recur; or by alcohol or illicit 
drug withdrawal.
     Examples of moderate-to-high-risk factors for recurrence 
include seizures caused by non-penetrating head injury with loss of 
consciousness or amnesia greater than 30 minutes or penetrating head 
injury; intracerebral hemorrhage associated with a stroke or trauma; 
infections; intracranial hemorrhage; post-operative complications from 
brain surgery with significant brain hemorrhage; brain tumor; or 
stroke.
    The MEP report indicates that individuals with moderate to high-
risk conditions should not be certified. Drivers with a history of a 
single provoked seizure with low risk factors for recurrence should be 
recertified every year.

Medical Review Board Recommendations and Agency Decision

    FMCSA presented the MEP's findings and the Evidence Report to the 
Medical Review Board (MRB) for consideration. The MRB reviewed and 
considered the 2007 ``Seizure Disorders and Commercial Driver Safety'' 
evidence report and the 2007 MEP recommendations. The MRB recommended 
maintaining the current advisory criteria, which provide that ``drivers 
with a history of epilepsy/seizures off anti-seizure medication and 
seizure-free for 10 years may be qualified to drive a CMV in interstate 
commerce. Interstate drivers with a history of a single unprovoked 
seizure may be qualified to drive a CMV in interstate commerce if 
seizure-free and off anti-seizure medication for a 5 year period or 
more'' [Advisory criteria to 49 CFR 391.43(f)].
    The Agency acknowledges the MRB's position on the issue but 
believes current relevant medical evidence supports a less conservative 
approach. The medical advisory criteria for epilepsy and other seizure 
or loss of consciousness episodes was based on the 1988 ``Conference of 
Neurological Disorders and Commercial Driving'' (NITS Accession No. 
PB89-158950/AS). A copy of the report can be found in the docket 
referenced in this notice.
    The MRB's recommendation treats all drivers who have experienced a 
seizure the same, regardless of individual medical conditions and 
circumstances. In addition, the recommendation to continue prohibiting 
drivers who are taking anti-seizure medication from operating a CMV in 
interstate commerce does not consider a driver's actual seizure history 
and time since the last seizure. The Agency has decided to use the 2007 
MEP recommendations as the basis for evaluating applications for an 
exemption from the seizure regulation on an individual, case-by-case 
basis. The disposition of applications announced in this notice applies 
the 2007 MEP recommendations.

Denials and Reasons

     The following driver was listed previously in Federal 
Register Notice FMCSA-2011-0089 published April 05, 2011:
    Darren Keith--Mr. Keith has a history of a seizure disorder. His 
last seizure was in 2009. He will have been seizure-free for 8 years, 
as required by the MEP guidelines, in 2017. He may reapply at that 
time.
     The following drivers were listed previously in Federal 
Register Notice FMCSA-2011-0389 published January 05, 2012:
    Christopher Boddie--Mr. Boddie has a history of a seizure in 2011. 
He does not meet the exemption criteria at this time.
    Roger Corvasce--We were unable to contact Mr. Corvasce by phone or 
mail to ascertain his status.
    Michael Drake--Mr. Drake has a history of epilepsy. His last 
seizure was in 2009. He will have been seizure-free

[[Page 59348]]

for 8 years, as required by the MEP guidelines, in 2017. He may reapply 
at that time.
    Virgil Godbey--We were unable to contact Mr. Godbey by phone or 
mail to ascertain his status.
    Glen Hogan--Mr. Hogan withdrew his request for a seizure exemption.
    Jordan Hyster--Mr. Hyster has a diagnosis of epilepsy, and his last 
seizure was 2009. He will have been seizure-free for 8 years, as 
required by the MEP guidelines, in 2017. He may reapply at that time.
    Phillip McLain--Mr. McLain withdrew his request for a seizure 
exemption.
    Mark Smith--Mr. Smith has a history of a seizure disorder. His last 
seizure was in 2010. He will have been seizure-free for 8 years, as 
required by the MEP guidelines, in 2018. He may reapply at that time.
    Cheryl Woskie -We were unable to contact Ms. Woskie by phone mail 
to ascertain her status.
     The following drivers were listed previously in Federal 
Register Notice FMCSA-2012-0050 published on February 29, 2012:
    Darren Carroll--Mr. Carroll has a history of a seizure in 2011. He 
does not meet the exemption criteria at this time.
    Charles Johnson--Mr. Johnson has a history of a seizure disorder. 
His last seizure was in 2011. He will have been seizure-free for 8 
years, as required by the MEP guidelines, in 2019.
    He may reapply at that time.
     The following drivers were listed previously in Federal 
Register Notice FMCSA-2012-0094 published on January 15, 2013:
    Sonja Cottle--Ms. Cottle does not require an exemption from the 
epilepsy and seizure standard because she does not have a history of 
seizure and is not taking anti-seizure medication.
    Jeffrey Davis--Mr. Davis has a history of a seizure in 2011. He 
does not meet the exemption criteria at this time.
    Juan Flores--Mr. Flores has a history of a seizure disorder. His 
last seizure was in 2011. He will have been seizure-free for 8 years, 
as required by the MEP guidelines, in 2019. He may reapply at that 
time.
    Glenn Gervais--Mr. Gervais has a history of a seizure in 2011. He 
does not meet the exemption criteria at this time.
    Daryl Goodman--We were unable to contact Mr. Goodman by phone or 
mail to ascertain his status.
    Gary Osley--We were unable to contact Mr. Osley by phone or mail to 
ascertain his status.
     The following driver was listed previously in Federal 
Register Notice FMCSA-2013-0106 published on April 24, 2013:
    James Kivett - Mr. Kivett has a history of a seizure in 2011. He 
does not meet the exemption criteria at this time.
     The following driver was listed previously in Federal 
Register Notice FMCSA-2013-0108 published on September 16, 2013:
    Paul Kane--Mr. Kane has a diagnosis of epilepsy, and his last 
seizure was 2009. He will have been seizure-free for 8 years, as 
required by the MEP guidelines, in 2017. He may reapply at that time.
     The following drivers were listed previously in Federal 
Register Notice FMCSA-2013-0109 published on November 13, 2013:
    Montie Bullis--Mr. Bullis has a diagnosis of a seizure disorder, 
and his last seizure was in 2009. He will have been seizure-free for 8 
years, as required by the MEP guidelines, in 2017. He may reapply at 
that time.
    Rick Cote--Mr. Cote has a diagnosis of epilepsy, and his last 
seizure was in 2009. He will have been seizure-free for 8 years, as 
required by the MEP guidelines, in 2017. He may reapply at that time.
    Barry Von Gulner--Mr. Von Gulner has a diagnosis of probable 
epilepsy, and his last seizure was in 2008. He will have been seizure-
free for 8 years, as required by the MEP guidelines, in 2016. He may 
reapply at that time.
    John Welch--Mr. Welch has a diagnosis of epilepsy, and his last 
seizure was in 2000. He discontinued his anti-seizure medication in 
2009. He will have been stable, off of anti-seizure medication for 8 
years, as required by the MEP guidelines, in 2017.

    Issued On: September 23, 2014.
Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2014-23437 Filed 9-30-14; 8:45 am]
BILLING CODE 4910-EX-P